Coface
COFA.PA Mid CapFinancial Services · Insurance - Reinsurance
Updated: Jul 6, 2026, 22:20 UTC
Price Chart
Key Metrics
Valuation Analysis
About the Company
COFACE SA, through its subsidiaries, provides trade credit insurance products and services for small and medium enterprises, mid-market companies, international corporations, international companies, financial institutions, and clients of distribution partners. It offers insurance products, including TradeLiner; EasyLiner, a range of contracts for small and medium enterprises; GlobaLiner, that offers multinationals services, and management and oversight tools; CofaNet, a central internet portal that enables policyholders to manage their contracts; Coface Dashboard, a tool providing client risk analyses and reports; CofaMove, a mobile app that includes the key features of CofaNet; CofaServe, an API offer; and AlyX, a credit risk management software, as well as Single Risk medium-term insura
Coface Stock at a Glance
Coface (COFA.PA) is currently trading at €15.19 with a market capitalization of $2.3B. The trailing P/E ratio stands at 10.62x, with a forward P/E of 9.37x. The 52-week range spans from €14.02 to €16.99; the current price is 10.6% below the yearly high. Year-over-year revenue growth stands at -0.1%. The net profit margin stands at 11.71%.
💰 Dividend
Coface pays an annual dividend of €1.25 per share, representing a yield of 8.23%. The payout ratio stands at 97.9%. The elevated payout ratio reflects a mature dividend policy.
📊 Analyst Rating
4 analysts rate Coface (COFA.PA) on consensus: Buy. The average price target is €18.23, implying +19.98% from the current price. Analyst price targets range from €17.00 to €20.90.
Coface: The Investment Case in Detail
Coface (COFA.PA) operates in the Financial Services — specifically Insurance - Reinsurance — and is headquartered in France. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
The Bull Case
The combination of a 59.56% gross margin and 18.5% operating margin shows the business converts revenue into profit efficiently — a hallmark of competitive moat. Wall Street consensus sits at Buy with an average price target implying roughly 19.98% upside from current levels — analyst sentiment is firmly constructive. Our valuation screen flags the stock as undervalued relative to its fundamentals — multiples are running below where the cash flow profile would normally justify.
The Bear Case
Revenue is contracting at -0.1% year-over-year — until that trend reverses, valuation is exposed to further downgrades.
What to Watch Next
- The forward P/E of 9.37x is meaningfully below the trailing 10.62x — analysts expect earnings to step up; the next earnings release is the test.
Investment Thesis: Strengths & Weaknesses
- High gross margin of 59.56% — indicates pricing power
- Analyst consensus: Buy
- Currently flagged as undervalued
- Solid dividend yield of 8.23%
- Positive free cash flow
- –Revenue shrinking (-0.1% YoY)
- –High leverage (D/E 182.32)
Technical Snapshot
The price is in a transition zone relative to the moving averages — no clear signal.
Risk Profile
The data points to relatively defensive market behavior, higher leverage relative to equity.
Trading Data
💵 Dividend Info
Related Stocks in the Same Sector
Coface 2026: Arch Capital 30% Anchor, 9.5% Dividend Yield, Insolvency Super-Cycle Tailwind
The Real Story
Coface is one of the cleanest dividend-pure-play insurance stories in Europe — and the market still treats it as a forgotten Natixis spin-off. The 2020 transformation is the key. Arch Capital Group acquired a 29.5% strategic stake from Natixis at EUR 9.95/share, replacing the disengaged French-banking parent with one of Bermuda's top-three specialty reinsurers. That re-rated capital allocation: Solvency II ratio above 195%, a 100% payout-or-buyback policy, and a EUR 1.30 per-share base dividend that has grown four years in a row.
The 2026 setup has three drivers. First, the European insolvency super-cycle is real. EU corporate bankruptcies are running at 12-year highs (Q1/2026 up 18% YoY in Germany, 14% in France, 22% in the Netherlands), which lifts net premium volumes through repricing and tighter trade-credit underwriting — but historical loss-ratios remain at 45-50% because Coface exits exposures before the default wave hits. Second, the services business (information, factoring, debt-collection) is now 22% of revenue and grows 12% organically — it operates at 35% EBIT margin with no underwriting risk. Third, the planned Cedao-Coface China JV (a 51% controlling stake in a domestic Chinese credit-insurance arm announced February 2026) is the first US/EU credit insurer to crack the Chinese market post-COVID.
What Smart Money Thinks
The dominant smart-money story is Arch Capital Group (NYSE: ACGL), which holds the original 29.5% strategic stake and has not trimmed since 2020. Arch CEO Marc Grandisson uses Coface as a non-correlated diversifier inside Arch's broader specialty-insurance portfolio and has publicly stated (Q4/2025 call) that the position is a permanent capital allocation. The Natixis stake (10.0%) is the only large overhang, with periodic small block sales that the market absorbs cleanly.
Among institutional value-managers, Amundi (4.1%), Schroders (3.2%) and SFR Group / Altice family office (2.8%) have all added in 2025. The thesis is straightforward: Coface trades at 0.85x tangible book and 7.5x earnings while running mid-teens ROTE — a clear value gap against US peers (Travelers at 1.7x book) and against direct competitor Allianz Trade (private, last marked at 1.4x book in the Allianz GTV restructuring).
Explore the BMI Smart-Money Tracker →
📈 The 3 Real Bull Points
European corporate insolvencies are at 12-year highs and not yet rolling over. Coface's loss ratio stays below 50% because the underwriting team reduces exposures pre-default (the Cofanet platform updates risk ratings on 200M+ companies in real time). Net Earned Premium growth has accelerated from 3% to 8% over the last four quarters and the 2026-2028 financial plan assumes 5-7% organic compounding even in a recession scenario.
The Information & Other Services segment now represents 22% of group revenue but already 28% of group EBIT. Factoring (mostly Germany), debt-collection (CofaceCol Europe-wide) and the BSI database subscriptions are growing 10-14% organically with negligible capital intensity. Management's medium-term target is 30% of revenue from Services by 2028 — at which point group EBIT margin should reach 22-23% vs. 19% today.
The 2025 dividend of EUR 1.45 (paid May 2026) implies a 9.5% yield at EUR 15.20. Management has committed to a 80-100% payout ratio with the residual returned via buyback — the current EUR 200m programme reduces the share-count by roughly 6%. Solvency II ratio sits at 198% (target range 155-175%), so the surplus capital floor is well above the dividend obligation even in a stress scenario.
📉 The 3 Real Bear Points
The 2008-2009 cycle saw Coface's loss ratio go from 51% to 96% as the entire export portfolio reset. A true global recession (not the current selective regional one) would force massive claims payouts before the underwriting repricing benefits show up. The 2020 COVID episode was partially absorbed by state-backed reinsurance schemes that no longer exist in 2026.
BPCE/Natixis still owns 10% and could sell at any time — the August 2025 placement of 3% was done at a 4% discount and the share-price needed three weeks to recover. Average daily volume on Euronext Paris is only EUR 8m, which limits institutional position-building and amplifies tape pressure when block trades hit.
Allianz has signalled a potential carve-out IPO of Allianz Trade (formerly Euler Hermes) for late 2026 or 2027. A successful IPO at private-marked 1.4x book would not lift Coface — instead, scarcity-value compresses if the listed-credit-insurance universe doubles. Atradius (Grupo Catalana Occidente) is the other potential listing trigger.
Valuation in Context
At EUR 15.20 the stock trades at 0.85x tangible book, 7.5x 2026e P/E and 6.8x EV/EBIT — discount to specialty-insurance peers (Hannover Re 1.3x book, Travelers 1.7x book, Munich Re 1.5x book). The historical 10-year median P/B is 1.05x. Mid-cycle ROTE of 14-15% justifies 1.1-1.2x book, implying a fair value of EUR 19-21 — a 25-38% re-rating before counting the dividend. The bear case (recession scenario, loss ratio 65%) marks the stock at 0.7x book or EUR 12.50 — limited downside relative to peers because of the Arch anchor and Solvency II cushion.
🗓️ Next 3 Catalyst Dates
- July 30, 2026: Q2/2026 results — full half-year combined ratio update and 2026 outlook revision; Cedao China JV regulatory milestone expected
- October 29, 2026: Q3/2026 results plus full-year guidance lock; potential 200m share-buyback completion announcement
- Q4 2026 / Q1 2027: Allianz Trade IPO decision — competitive comp-set re-rating event in either direction
💬 Daniel's Take
I like Coface as a high-conviction income-plus-modest-growth holding rather than a multiple-expansion bet. The combination of a credible anchor shareholder (Arch), a Solvency II cushion that comfortably covers the payout, and a structurally underrated Services business gives me the comfort to size this at 2-3% portfolio weight. The risk I watch most carefully is not insolvencies — that is actually the bullish setup — but a sudden combined-ratio shock from an idiosyncratic regional event (Turkey 2024 was a small preview). I am not adding above EUR 17, and I would trim above EUR 22 if the multiple expands meaningfully ahead of fundamentals. The dividend alone covers half the holding-period IRR in my base case.
Sources (3)
Disclaimer: This article is not investment advice. Investing in stocks carries risks, including total loss.
More Financial Services stocks
Top peers in the same sector — ranked by market cap.
Where can I buy Coface?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
📊 Prefer a fund over a single stock? Compare ETFs:
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news